GIVEN DOUGLAS B

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$43,472.35
Insider Sells Quantity
21
Insider Sells Sum
$5.73M

Insider Activity of GIVEN DOUGLAS B

According to the SEC Form 4 filings, GIVEN DOUGLAS B, being in a position of

  1. director at Arrowhead Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 8458 shares for $232,344,
    over all time since 2014-08-15, has bought 655 shares for $43,472, and sold 242033 shares for $5.73M.

The largest purchase of all time was on 2021-12-28 and amounted to 655 shares of Arrowhead Pharmaceuticals, Inc. for $43,472.

The largest sale of all time was on 2019-02-26 and amounted to 65000 shares of Arrowhead Pharmaceuticals, Inc. for $1.25M.

Biography of GIVEN DOUGLAS B

No biography is available at this moment.

2024-12-17SaleArrowhead Pharmaceuticals, Inc.
ARWR
director
547
0.0004%
$22.04$12,056-12.66%
2024-12-16SaleArrowhead Pharmaceuticals, Inc.
ARWR
director
5,000
0.004%
$21.90$109,500-6.75%
2024-01-11SaleArrowhead Pharmaceuticals, Inc.
ARWR
director
2,911
0.0028%
$38.06$110,788-34.11%
2023-05-05SaleArrowhead Pharmaceuticals, Inc.
ARWR
director
6,500
0.006%
$40.90$265,850-29.63%
2023-02-27SaleArrowhead Pharmaceuticals, Inc.
ARWR
director
875
0.0008%
$32.62$28,543-8.07%
2021-12-28PurchaseArrowhead Pharmaceuticals, Inc.
ARWR
director
655
0.0006%
$66.37$43,472-39.41%
2021-09-09SaleArrowhead Pharmaceuticals, Inc.
ARWR
director
5,000
0.0048%
$65.24$326,200-28.14%
2021-06-22SaleArrowhead Pharmaceuticals, Inc.
ARWR
director
4,500
0.0043%
$89.21$401,445-31.81%
2021-02-22SaleArrowhead Pharmaceuticals, Inc.
ARWR
director
1,125
0.0011%
$88.73$99,821-21.47%
2021-01-15SaleArrowhead Pharmaceuticals, Inc.
ARWR
director
3,000
0.003%
$83.28$249,840-15.7%
2021-01-04SaleArrowhead Pharmaceuticals, Inc.
ARWR
director
4,000
0.0039%
$76.08$304,320-7.79%
2020-12-17SaleArrowhead Pharmaceuticals, Inc.
ARWR
director
9,575
0.0093%
$79.32$759,443-12.32%
2020-04-14SaleArrowhead Pharmaceuticals, Inc.
ARWR
director
25,000
0.0246%
$36.89$922,250+33.08%
2019-02-26SaleArrowhead Pharmaceuticals, Inc.
ARWR
director
65,000
0.0694%
$19.25$1.25M+54.18%
2019-02-22SaleArrowhead Pharmaceuticals, Inc.
ARWR
director
3,000
0.0031%
$18.05$54,150+59.13%
2019-01-22SaleArrowhead Pharmaceuticals, Inc.
ARWR
director
6,000
0.0066%
$13.58$81,480+115.42%
2018-12-27SaleArrowhead Pharmaceuticals, Inc.
ARWR
director
6,000
0.0066%
$12.00$72,000+125.73%
2018-11-23SaleArrowhead Pharmaceuticals, Inc.
ARWR
director
6,000
0.0065%
$12.74$76,440+87.77%
2018-04-24SaleArrowhead Pharmaceuticals, Inc.
ARWR
director
50,000
0.058%
$6.63$331,500+122.55%
2016-10-14SaleArrowhead Pharmaceuticals, Inc.
ARWR
director
24,000
0.034%
$6.72$161,280-72.29%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.